Analysis of complications after liver surgery
Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy
This study looks at the problems that can happen after liver surgery to help doctors understand how to prevent them and improve recovery for patients aged 18-80.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06532214 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes postoperative complications following hepatectomy, a surgical procedure for treating liver diseases. It aims to provide a comprehensive understanding of the incidence, risk factors, and prevention strategies for complications such as liver failure and infections. By reviewing data from patients aged 18-80 who underwent liver resection at participating centers, the study seeks to fill gaps in existing research that often focuses on small samples or specific complications. The findings could help improve patient outcomes and reduce healthcare costs associated with these complications.
Who should consider this trial
Good fit: Ideal candidates are patients aged 18-80 who have undergone liver resection surgery.
Not a fit: Patients with prior cancer treatments, repeat liver surgeries, or concurrent end-stage diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management and prevention of postoperative complications in liver surgery patients.
How similar studies have performed: While there have been smaller studies on specific complications, this comprehensive analysis approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Patients aged 18-80 years 2.Patients who underwent liver resection surgery at the participating centers Exclusion Criteria: * Exclusion criteria are as follows: 1. Prior cancer treatments such as transarterial chemoembolization, ablation, or targeted therapy. 2. Repeat liver resection surgeries. 3. Presence of other malignancies. 4. Concurrent end-stage diseases including active infections, respiratory failure, decompensated heart failure, and autoimmune disease exacerbations. 5. Inadequate clinical data availability in medical records.
Where this trial is running
Guangzhou, Guangdong
- Nanfang Hospital — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Kai Wang
- Email: kaiwang@smu.edu.cn
- Phone: 13710574386
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.